The Full Federal Court on Tuesday dismissed an appeal by aviation services company Aerocare of a ruling rejecting an enterprise agreement the Transport Workers Union called “substandard”.
The financing arrangement underwriting Quinn Emanuel’s shareholder class action against AMP, which will earn its partner Burford Capital a record low 10 percent of any recovery, sets a new standard in class action litigation funding, and is expected to spark greater price competition in the industry.
Apple has lost its bid to be represented by an outside lawyer in an unfair dismissal dispute, with the Fair Work Commission saying Monday the case was not inherently complex and the company’s inhouse legal counsel had time to bone up employment litigation.
A bidding war erupted Tuesday among law firms angling to lead a $2 billion shareholder class action against AMP, with Maurice Blackburn announcing a “super deal” and Quinn Emanuel besting that with a funding arrangement to “shake up” the market.
The fraud case against Australian basketball great Shane Heal has been withdrawn after prosecutors’ could not get their US-based star witness to testify in time.
A Sydney-based IT consultant faces multiple charges of insider trading after illegally accessing stock information from a financial publisher, the Australian Securities and Investments Commission said Monday.
The ACCC is considering a report by US-based Oracle into Google’s tracking of Australian Android phone users as part of the regulator’s broader inquiry into digital media.
A Victorian Supreme Court judge has recused himself from proceedings over costs in a construction dispute, after vowing to send transcripts of the case to the state’s legal watchdog.
Telecom giant Optus has come up short in a Federal Court challenge to trademark registration for health services company Optum, with a judge saying the two company’s marks — despite the difference of just one letter — were distinct enough.
A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic versions of its sustained-release Panadol.